Justin M. Hall

2021 - NovaBay Pharmaceuticals

In 2021, Justin M. Hall earned a total compensation of $795.5K as CEO, GC and Chief Compliance Officer at NovaBay Pharmaceuticals, a 6% increase compared to previous year.

Compensation breakdown

Bonus$70,000
Salary$328,667
Stock Awards$395,000
Other$1,854
Total$795,521

Hall received $395K in stock awards, accounting for 50% of the total pay in 2021.

Hall also received $70K in bonus, $328.7K in salary and $1.9K in other compensation.

Rankings

In 2021, Justin M. Hall's compensation ranked 9,494th out of 12,415 executives tracked by ExecPay. In other words, Hall earned more than 23.5% of executives.

ClassificationRankingPercentile
All
9,494
out of 12,415
24th
Division
Manufacturing
4,210
out of 5,505
24th
Major group
Chemicals And Allied Products
1,865
out of 2,375
22nd
Industry group
Drugs
1,654
out of 2,096
21st
Industry
Pharmaceutical Preparations
1,230
out of 1,546
20th
Source: SEC filing on March 30, 2022.

Hall's colleagues

We found two more compensation records of executives who worked with Justin M. Hall at NovaBay Pharmaceuticals in 2021.

2021

Andrew Jones

NovaBay Pharmaceuticals

Chief Financial Officer

2021

Audrey Kunin

NovaBay Pharmaceuticals

Chief Product Officer

News

You may also like